Shanghai Haohai Biological Tech Co (688366) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haohai Biological Tech Co (688366) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥109.13 Million ≈ $15.97 Million USD) by net assets (CN¥5.88 Billion ≈ $861.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shanghai Haohai Biological Tech Co - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Shanghai Haohai Biological Tech Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Shanghai Haohai Biological Tech Co for a breakdown of total debt and financial obligations.
Shanghai Haohai Biological Tech Co Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haohai Biological Tech Co ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Karnataka Bank Limited
NSE:KTKBANK
|
0.185x |
|
OceanFirst Financial Corp
NASDAQ:OCFC
|
0.022x |
|
Tiangong International Company Limited
F:34T1
|
0.010x |
|
EUREKA FORBES LTD
NSE:EUREKAFORB
|
N/A |
|
Juewei Food Co Ltd
SHG:603517
|
0.019x |
|
Nazara Technologies Limited
NSE:NAZARA
|
0.009x |
|
Teva Pharmaceutical Industries Ltd
TA:TEVA
|
0.193x |
|
Sivers IMA Holding AB
ST:SIVE
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Shanghai Haohai Biological Tech Co (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Haohai Biological Tech Co from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Shanghai Haohai Biological Tech Co worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.92 Billion ≈ $865.85 Million |
CN¥648.57 Million ≈ $94.91 Million |
0.110x | +3.96% |
| 2023-12-31 | CN¥6.02 Billion ≈ $880.52 Million |
CN¥634.45 Million ≈ $92.84 Million |
0.105x | +169.06% |
| 2022-12-31 | CN¥5.90 Billion ≈ $863.70 Million |
CN¥231.30 Million ≈ $33.85 Million |
0.039x | -30.62% |
| 2021-12-31 | CN¥6.06 Billion ≈ $886.81 Million |
CN¥342.29 Million ≈ $50.09 Million |
0.056x | +23.58% |
| 2020-12-31 | CN¥5.73 Billion ≈ $839.10 Million |
CN¥262.07 Million ≈ $38.35 Million |
0.046x | -25.95% |
| 2019-12-31 | CN¥5.65 Billion ≈ $827.26 Million |
CN¥348.91 Million ≈ $51.06 Million |
0.062x | -39.50% |
| 2018-12-31 | CN¥3.84 Billion ≈ $561.25 Million |
CN¥391.28 Million ≈ $57.26 Million |
0.102x | +0.12% |
| 2017-12-31 | CN¥3.37 Billion ≈ $492.65 Million |
CN¥343.06 Million ≈ $50.20 Million |
0.102x | +19.56% |
| 2016-12-31 | CN¥2.99 Billion ≈ $436.93 Million |
CN¥254.49 Million ≈ $37.24 Million |
0.085x | -15.39% |
| 2015-12-31 | CN¥2.67 Billion ≈ $390.04 Million |
CN¥268.51 Million ≈ $39.29 Million |
0.101x | -57.85% |
| 2014-12-31 | CN¥594.16 Million ≈ $86.94 Million |
CN¥141.99 Million ≈ $20.78 Million |
0.239x | -11.33% |
| 2013-12-31 | CN¥545.05 Million ≈ $79.76 Million |
CN¥146.91 Million ≈ $21.50 Million |
0.270x | -10.48% |
| 2012-12-31 | CN¥393.33 Million ≈ $57.56 Million |
CN¥118.42 Million ≈ $17.33 Million |
0.301x | -- |
About Shanghai Haohai Biological Tech Co
Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyal… Read more